NCNA

NuCana

1NCNA
GBR
NASDAQ

$2.96

24H

Market Cap

6.7 M

Volume

3.2 K

Supply

2.3 M

Price Chart

About NuCana - NCNA

NuCana plc is a biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying its ProTide technology to transform some of the most widely prescribed chemotherapy agents into more effective and safer medicines.

What are NuCana's core values and mission statement?

NuCana plc, a pharmaceutical company, focuses on improving treatment outcomes for cancer patients by developing medicines based on its proprietary phosphoramidate chemistry. Their mission is to develop these medications to overcome key cancer resistance mechanisms and generate much-needed treatment options for patients.

Who founded NuCana and when?

NuCana plc was founded by Hugh S. Griffith in 2008.

Who leads NuCana?

As of the last available information, Hugh S. Griffith is the founder and CEO of NuCana plc.

Where is NuCana located, and what is its base country?

NuCana plc is located in Edinburgh, Scotland, and its base country is the United Kingdom.

On which exchanges is NuCana traded?

NuCana plc is traded on the NASDAQ under the ticker symbol NCNA.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open/Close
Low/High
Volume
Cap

NuCana (NCNA) Price Live Data

The live price of NuCana (NCNA) is $2.96, with a trading volume of 3,165 in the last 24 hours. Wrapstocks updates the NCNA price in real-time. NuCana is up 0% in the last 24 hours. The company has a live market cap of $6,708,544.00 and a supply of 2,266,400 NCNA stocks.

NuCana (NCNA) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 15 hours and 4 minutes.

Exchange
NASDAQ
NASDAQ
NASDAQ Stock Exchange
USA
Opens in
15 hours and 4 minutes
Working Hours
Mon-Fri, 01:30 PM - 08:00 PM
Timezone
GMT+0
Last Updated
19 Jun 2024 07:56 PM